ESMO Presentation, page-3

First 3 Last

Share
Profile

Follow
harvett

6,853 Posts.

2537

06/03/18

09:04

Post #: 31547167
Share

Originally posted by RBx ↑

Harvett has contended that the results for NOX66 plus Carboplatin presented today are similar to those achieved many years ago with Phenoxodiol delivered intravenously. He is wrong.

What he has missed, in his zeal to disparage Noxopharm, is that Carboplatin was administered at NON-TOXIC levels (AUC=4) which on its own would have absolutely no effect.

The addition of NOX66 at 800mg had two significant effects: (1) it stopped disease progression in nearly every patient, without side effects; and (2) it provided proof that 800mg would be the best dose of NOX66 to use in radiotherapy trials.

Ask yourself this: if you had terminal cancer that had failed all treatment and had weeks to live, would you want to be treated with a toxic dose of chemo that had stopped working, or would you prefer to be treated with a non-toxic dose of that chemo plus NOX66 in the knowledge that your cancer would most likely stop growing?

Idronoxil delivered by suppository is VASTLY superior to intravenous Phenoxodiol. This is a great result

Expand

My point was efficacy would be just enough to warrant further investigation. And it is. "Vastly superior" when there was not this time one complete response at all.

NOX Price at posting: $1.50 Sentiment: None Disclosure: Not Held
2 Upvote

1 Great analysis

Reply

Top Stories

ASX Market Open: After worst day in 3 months, bourse could only really bounce back | July 22

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

PTX

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

ASX Market Close: Climbing to 8,700s based on vibes wasn't sustainable

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 6.8¢		Change 0.000(0.00%)		Mkt cap ! $19.87M

Open	High	Low	Value	Volume
6.7¢	6.8¢	6.7¢	$7.861K	117.1K

Buyers (Bids)

No.	Vol.	Price($)
1	59378	6.6¢

Sellers (Offers)

Price($)	Vol.	No.
6.8¢	43369	1

View Market Depth

No.	Vol.	Price($)
1	59378	0.066
1	20000	0.065
1	16393	0.061
1	20000	0.059
1	15000	0.058

Price($)	Vol.	No.
0.068	43369	1
0.070	261666	1
0.072	43942	1
0.080	100000	1
0.081	12345	1

Last trade - 15.25pm 21/07/2025 (20 minute delay)

NOX (ASX) Chart

ESMO Presentation, page-3

ASX Market Open: After worst day in 3 months, bourse could only really bounce back | July 22

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

ASX Market Close: Climbing to 8,700s based on vibes wasn't sustainable

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

ESMO Presentation, page-3

Top Stories

ASX Market Open: After worst day in 3 months, bourse could only really bounce back | July 22

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

ASX Market Close: Climbing to 8,700s based on vibes wasn't sustainable

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News